SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (3143)6/3/1998 8:17:00 AM
From: Perry  Respond to of 9523
 
From the most recent news it appears that there are absolutely no contenders to Viagra. If the stock price lately is a reflection of possible future competition then PFE is certainly a bargain. It appears odd that some of the ED drugs that affect blood flow would not have similar, if not greater, cardiovascular side effects to that of Viagra. The bad news on VVUS should help PFE today.

Good luck.
Perry



To: BigKNY3 who wrote (3143)6/3/1998 1:04:00 PM
From: Riskmgmt  Read Replies (2) | Respond to of 9523
 
David Faber on PFE and compettion-now. CNBC